Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorSACHER, F.
dc.contributor.authorJESEL, L.
dc.contributor.authorBORNI-DUVAL, C.
dc.contributor.authorDE PRECIGOUT, V.
dc.contributor.authorLAVAINNE, F.
dc.contributor.authorBOURDENX, J. P.
dc.contributor.authorHADDJ-ELMRABET, A.
dc.contributor.authorSEIGNEURIC, B.
dc.contributor.authorKELLER, A.
dc.contributor.authorOTT, J.
dc.contributor.authorSAVEL, H.
dc.contributor.authorDELMAS, Y.
dc.contributor.authorBAZIN-KARA, D.
dc.contributor.authorKLOTZ, N.
dc.contributor.authorPLOUX, S.
dc.contributor.authorBUFFLER, S.
dc.contributor.authorRITTER, P.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRONDEAU, Virginie
dc.contributor.authorBORDACHAR, P.
dc.contributor.authorMARTIN, C.
dc.contributor.authorDEPLAGNE, A.
dc.contributor.authorREUTER, S.
dc.contributor.authorHAISSAGUERRE, M.
dc.contributor.authorGOURRAUD, J. B.
dc.contributor.authorVIGNEAU, C.
dc.contributor.authorMABO, P.
dc.contributor.authorMAURY, P.
dc.contributor.authorHANNEDOUCHE, T.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBENARD, Antoine
dc.contributor.authorCOMBE, C.
dc.date.accessioned2021-01-04T13:37:16Z
dc.date.available2021-01-04T13:37:16Z
dc.date.issued2018-03
dc.identifier.issn2405-500xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/23618
dc.description.abstractEnOBJECTIVES: The aim of this study was to identify using implantable loop recorder (ILR) monitoring the mechanisms leading to sudden death (SD) in patients undergoing hemodialysis (HD). BACKGROUND: SD accounts for 11% to 25% of death in HD patients. METHODS: Continuous rhythm monitoring was performed using the remote monitoring capability of the ILR device in patients undergoing HD at 8 centers. Clinical, biological, and technical HD parameters were recorded and analyzed. RESULTS: Seventy-one patients (mean age 65 +/- 9 years, 73% men) were included. Left ventricular ejection fraction was <50% in 16%. Twelve patients (17%) had histories of atrial fibrillation or flutter at inclusion. During a mean follow-up period of 21.3 +/- 6.9 months, 16 patients died (14% patient-years), 7 (44%) of cardiovascular causes. Four SDs occurred, with progressive bradycardia followed by asystole. The incidence of patients presenting with significant conduction disorder and with ventricular arrhythmia was 14% and 9% patient-years, respectively. In multivariate survival frailty analyses, a higher risk for conduction disorder was associated with plasma potassium >5.0 mmol/l, bicarbonate <22 mmol/l, hemoglobin >11.5 g/dl, pre-HD systolic blood pressure >140 mm Hg, the longer interdialytic period, history of coronary artery disease, previous other arrhythmias, and diabetes mellitus. A higher risk for ventricular arrhythmia was associated with potassium <4.0 mmol/l, no antiarrhythmic drugs, and previous other arrhythmias. With ILR monitoring, de novo atrial fibrillation or flutter was diagnosed in 14 patients (20%). CONCLUSIONS: ILR may be considered in HD patients prone to significant conduction disorders, ventricular arrhythmia, or atrial fibrillation or flutter to allow early identification and initiation of adequate treatment. Therapeutic strategies reducing serum potassium variability could decrease the rate of SD in these patients. (Implantable Loop Recorder in Hemodialysis Patients [RYTHMODIAL]; NCT01252823).
dc.language.isoENen_US
dc.subject.enBiostatistics
dc.subject.enUSMR
dc.subject.enEMOS
dc.title.enCardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters
dc.title.alternativeJACC Clin Electrophysiolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jacep.2017.08.002en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30089568en_US
bordeaux.journalJACC. Clinical electrophysiologyen_US
bordeaux.page397-408en_US
bordeaux.volume4en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamBIOSTAT_BPHen_US
bordeaux.teamUSMRen_US
bordeaux.teamEMOSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=JACC.%20Clinical%20electrophysiology&amp;rft.date=2018-03&amp;rft.volume=4&amp;rft.issue=3&amp;rft.spage=397-408&amp;rft.epage=397-408&amp;rft.eissn=2405-500x&amp;rft.issn=2405-500x&amp;rft.au=SACHER,%20F.&amp;JESEL,%20L.&amp;BORNI-DUVAL,%20C.&amp;DE%20PRECIGOUT,%20V.&amp;LAVAINNE,%20F.&amp;rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée